maybe this will be the catalyst to drive s/p , page-2

May be if RP and the new board can attend that annual forum and do a talk on that basis.

The problem is management don't know how to capitalise on the recent H7N9 avian flu outbreak...

They need some positive show case and the buy buy buy recommendations from instos to improve the share price..

Something like this may help...

http://finance.yahoo.com/news/biota-pharmaceuticals-initiated-buy-guggenheim-123627009.html